Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

NOAH calls for UK-EU vet medicine agreement
"Veterinary medicines must not be sidelined as a technical detail" - Dawn Howard, NOAH chief executive.
Political leaders will meet for a summit on 19 May.

The National Office of Animal Health (NOAH) has united with its EU counterpart, AnimalhealthEurope, to call for a veterinary medicines agreement between the UK and EU.

The groups warn that, since the UK's exit from the European Union, there has been no formal regulatory agreement on veterinary medicines.

They maintain that a veterinary agreement is vital not only for treating pets and livestock, but also to protect public health, ensure food security and support sustainable agriculture. Animal welfare in both the UK and the EU could be at risk.

A lack of regulatory co-operation is currently causing challenges which threaten product availability and innovation. While other regulatory agreements have diverged since Brexit, NOAH says that a lack of alignment in the veterinary medicines sector has caused unnecessary duplication, increased costs and risks to availability.

Political leaders are set to meet for the EU-UK Summit in London on 19 May 2025. NOAH and AnimalhealthEurope hope they will use the opportunity to agree on a dedicated veterinary medicines agreement.

The organisations suggest that the leaders could either agree on a standalone deal or include it as a specific chapter in a broader Sanitary and Phytosanitary (SPS) Agreement. NOAH and AnimalhealthEurope believe this will mean continued alignment across product authorisation, labelling, distribution and post-market surveillance.

Dawn Howard, chief executive of NOAH, said: “Veterinary medicines must not be sidelined as a technical detail—they are critical to the health of our animals, the safety of our food, and the growth of our economy.”

She added: “This moment is a great opportunity. The UK and the EU have the chance to show leadership in animal health and welfare, economic co-operation, and One Health. NOAH, together with AnimalhealthEurope, is ready to work with regulators and policymakers to secure this outcome.”

Roxane Feller, secretary general of AnimalhealthEurope, said: “Unlike politics, disease knows no borders. Guaranteed access to veterinary medicines is fundamental to safeguarding animal health and welfare, ensuring food security, and protecting public health under the One Health framework.

“AnimalhealthEurope, together with NOAH, has been calling for cooperation in the field of veterinary medicines since the publication of the Withdrawal Agreement and Political Declaration on the future relationship between the UK and the EU in 2018.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.